Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely

Sponsor
NeuraLight
Study ID
NCT06597071
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
30 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • NeuraLight PD — OTHER
    NeuraLight software-based platform for PD patients
  • NeuraLight PSP — OTHER
    NeuraLight software-based platform for PSP patients
  • NeuraLight MSA — OTHER
    NeuraLight software-based platform for MSA patients
  • NeuraLight — OTHER
    NeuraLight software-based platform

Study Details

This is an observational longitudinal study in 4 cohorts of patients with Parkinsonian syndromes, who are visiting the Movement Disorders outpatient clinics. The aim of the study is to assess the difference of oculometric measures in different neurodegenerative brain conditions and their accuracy over time, and as compared to clinical diagnosis, in order to find a change over time, difference between subgroups and correlations with accepted clinical endpoints in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

Key Dates

First listed
Sep 19, 2024
Start date
Sep 10, 2024
Status verified
Sep 2024
Primary completion
Oct 1, 2025
Completion
Dec 1, 2025

Study Design

Enrollment
40 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Active Comparator: Parkinson patients
    Patients diagnosed with Parkinson's disease, ages 50-80, Hoehn \& Yahr scale 1-3
  • Active Comparator: PSP patients
    Patients diagnosed with PSP, according to actual diagnostic criteria from Höglinger GU et al, 2017.
  • Active Comparator: MSA patients
    Patients diagnosed with MSA, according to actual diagnostic criteria from Wenning et al, 2022.
  • Active Comparator: Healthy
    Healthy subjects with no neurological diseases or cognition deficits

Primary Outcome Measure

Change of saccadic latency between subgroups [ Time Frame: 12 months ]

Find similar trials

Nationwide
Parkinson's disease trialsNeurology trialsBrain disorders trials

Related Studies